+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Gestational Trophoblastic Disease Market Report 2025 - Product Thumbnail Image

Gestational Trophoblastic Disease Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Fms-like Tyrosine Kinase 3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Fms-like Tyrosine Kinase 3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 300 Pages
  • Global
From
Antibiotics Market Report 2023-2033 - Product Thumbnail Image

Antibiotics Market Report 2023-2033

  • Report
  • January 2023
  • 388 Pages
  • Global
From
From
Nivolumab Market Report 2025 - Product Thumbnail Image

Nivolumab Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Schizophrenia Market Report 2025 - Product Thumbnail Image

Schizophrenia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Hyperphosphatemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hyperphosphatemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Loading Indicator